View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
September 22, 2011

Anulex fiXate Tissue Band gets FDA clearance

Anulex Technologies has received US Food and Drug Administration (FDA) approval for its fiXate Tissue Band, designed to secure spinal cord stimulation lead anchors to the fascia or interspinous / supraspinous ligament in patients with chronic, intractable pain of the trunk or limbs.

By admin-demo

Anulex Technologies has received US Food and Drug Administration (FDA) approval for its fiXate Tissue Band, designed to secure spinal cord stimulation lead anchors to the fascia or interspinous / supraspinous ligament in patients with chronic, intractable pain of the trunk or limbs.

The fiXate Tissue Band provides consistent anchor securement through a delivery system that facilitates efficient fixation to the surrounding tissue.

Anulex executive chairman Jeff Peters said that, with the clearance of the fiXate Tissue Band, Anulex continues to demonstrate its commitment to developing novel and clinically relevant solutions for soft tissue fixation and repair.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management